๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
NewLake Capital Partners, Inc. (NLCP)
OTCMKTS ยท Delayed Price ยท Currency is USD
13.65
+0.09 (0.66%)
At close: Nov 18, 2026

NewLake Capital Partners Earnings Call Transcripts

Fiscal Year 2026

  • Q3 revenue and AFFO were in line with expectations, with 99.7% YTD rent collection and a debt-free balance sheet. Vacancies and tenant restructurings remain key offsets, while acquisitions and potential regulatory changes offer growth opportunities.

  • A 35-property cannabis real estate portfolio combines long leases, triple-net rent and no debt, with three vacancies and new transactions among growth avenues. Management sees regulatory change as a potential catalyst for industry growth and a future exchange uplisting.

  • The portfolio reported 100% year-to-date rent collection, zero debt, a 13% dividend yield and nearly 12 years of remaining lease duration. Management sees rescheduling, hemp restrictions and state-market expansion supporting sector growth and future investment opportunities.

  • Q2 2026 revenue and AFFO met expectations, with a strong balance sheet and 88% AFFO payout ratio. Portfolio resilience continues despite tenant challenges, and recent regulatory milestones support optimism for industry growth. Conservative leverage and new investments position the company well.

  • A leading cannabis real estate REIT with a disciplined, low-leverage approach, the firm benefits from regulatory catalysts like federal rescheduling and state-level hemp bans, driving tenant growth and above-market yields. Growth is supported by long-term leases, rent escalators, and expansion in limited-license states.

  • AGM 2026

    The meeting confirmed a quorum, reelected all seven board members, and ratified the independent auditor for 2026. No shareholder proposals or questions were raised, and final voting results will be filed with the SEC.

  • A leading cannabis-focused REIT highlighted its strong, low-leverage portfolio, robust dividend coverage, and growth from regulatory tailwinds, including cannabis rescheduling and state reforms. Institutional investment is expected to rise with potential uplisting, while federal actions against synthetic THC and illicit sales further support industry growth.

  • Q1 2026 results were in line with expectations, supported by strong liquidity, minimal debt, and a 90% AFFO payout ratio. Regulatory progress, including medical cannabis rescheduling, is expected to improve tenant credit and industry fundamentals.

  • Status update

    A cannabis-focused REIT with a high-yield, low-leverage portfolio, strong dividend coverage, and a cautious approach to new deals. Regulatory catalysts like rescheduling and 280E removal are expected to drive future growth, though sector volatility and capital market access remain challenges.

  • A cannabis-focused REIT highlighted its strong, low-leverage balance sheet, robust dividend growth, and strategic focus on limited license states for portfolio durability. Federal reforms and the SAFER Banking Act are seen as major catalysts for growth and market access.

Fiscal Year 2025

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022